Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus.
Resource Type
Editorial & Opinion
Authors
Buckley S; Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.; Subramaniam Y; Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.; Department of Diabetes and Metabolism, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Mallik R; Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.; Centre for Obesity Research, University College, London, UK.; Mukuba D; Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.; Casabar M; Department of Nephrology, The Royal London Hospital, London, UK.; Ali O; Department of Nephrology, The Royal London Hospital, London, UK.; Byrne C; Department of Nephrology, The Royal London Hospital, London, UK.; Chowdhury TA; Department of Diabetes and Metabolism, The Royal London Hospital, London, UK.
Source
Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE